Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase
Philip A. Harris(Centre Hospitalier de l’Université de Montréal), Robert W. Marquis(South College)
Cited by 69
Related Papers
Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches
|Clinical Cancer Research|2013|89